Overview
Neuroclues, a French-Belgian medtech startup, has raised €10 million in a Series A funding round, increasing its total funding to €25 million. The round was led by Teampact Ventures, White Fund, and the EIC Fund, addressing the challenge of neurodegenerative diseases through a compact, non-invasive device that analyzes eye movements to detect neurological disorders. This innovative technology aims to provide faster and more accurate diagnoses, with significant traction in European hospitals and research centers.
Products
Loading...
Recent Deals
Investors: Teampact Ventures, White Fund, EIC Fund
Neuroclues, a French-Belgian medtech startup, has raised €10 million in a Series A funding round, increasing its total funding to €25 million. The round was led by Teampact Ventures, White Fund, and the EIC Fund, addressing the challenge of neurodegenerative diseases through a compact, non-invasive device that analyzes eye movements to detect neurological disorders. This innovative technology aims to provide faster and more accurate diagnoses, with significant traction in European hospitals and research centers.